Pelizaeus-Merzbacher disease is a severe X-linked disorder of central myelination caused by mutations affecting the proteolipid protein gene. We describe 3 new PLP1 splicing mutations, their effect on splicing and associated phenotypes. Mutation c.453_453+6del7insA affects the exon 3B donor splice site and disrupts the PLP1-transcript without affecting the DM20, was found in a patient with severe Pelizaeus-Merzbacher disease and in his female cousin with early-onset spastic paraparesis. Mutation c.191+1G>A causes exon 2 skipping with a frame shift, is expected to result in a functionally null allele, and was found in a patient with mild Pelizaeus-Merzbacher disease and in his aunt with late-onset spastic paraparesis. Mutation c.696+1G>A utilizes a cryptic splice site in exon 5, causes partial exon 5 skipping and in-frame deletion, and was found in an isolated patient with a severe classical Pelizaeus-Merzbacher. PLP1 splice-site mutations express a variety of disease phenotypes mediated by different molecular pathogenic mechanisms.
InoueK.PLP1-related inherited dysmyelinating disorders: Pelizaeus-Merzbacher disease and spastic paraplegia type 2. Neurogenetics. 2005;6(1):1–16.
2.
SeitelbergerF. Neuropathology and genetics of Pelizaeus-Merzbacher disease. Brain Pathol. 1995;5(3):267–273.
3.
MilnerRJLaiCNaveKA, et al.Nucleotide sequences of two mRNAs for rat brain myelin proteolipid protein. Cell. 1985;42(3):931–939.
4.
GruenenfelderFIThomsonGPenderisJEdgarJM. Axon-glial interaction in the CNS: what we have learned from mouse models of Pelizaeus-Merzbacher disease. J Anat. 2011;219(1):33–43.
5.
NaveKALaiCBloomFEMilnerRJ. Splice site selection in the proteolipid protein (PLP) gene transcript and primary structure of the DM-20 protein of central nervous system myelin. Proc Natl Acad Sci USA. 1987;84(16):5665–5669.
6.
Pham-DinhDBirlingMCRousselG, et al.Proteolipid DM-20 predominates over PLP in peripheral nervous system. Neuroreport. 1991;2(2):89–92.
7.
IkenakaKKagawaTMikoshibaK.Selective expression of DM-20, an alternatively spliced myelin proteolipid protein gene product, in developing nervous system and in nonglial cells. J Neurochem. 1992;58(6):2248–2253.
8.
MimaultCGiraudGCourtoisV, et al.Proteolipoprotein gene analysis in 82 patients with sporadic Pelizaeus-Merzbacher Disease: duplications, the major cause of the disease, originate more frequently in male germ cells, but point mutations do not. Am J Hum Genet. 1999;65(2):360–369.
9.
KarimSABarrieJAMcCullochMC, et al.PLP/DM20 expression and turnover in a transgenic mouse model of Pelizaeus-Merzbacher disease. Glia. 2010;58(14):1727–1738.
10.
GrossiSRegisSBiancheriR, et al.Molecular genetic analysis of the PLP1 gene in 38 families with PLP1-related disorders: identification and functional characterization of 11 novel PLP1 mutations. Orphanet J Rare Dis. 2011;6:40.
11.
GarbernJYCambiFTangXM, et al.Proteolipid protein is necessary in peripheral as well as central myelin. Neuron. 1997;19(1):205–218.
12.
ShyMEHobsonGJainM, et al.Schwann cell expression of PLP1 but not DM20 is necessary to prevent neuropathy. Ann Neurol. 2003;53(3):354–365.
13.
TorisuHIwakiATakeshitaK, et al.Clinical and genetic characterization of a 2-year-old boy with complete PLP1 deletion. Brain Dev. 2012;34(10):852–856.
14.
GowASouthwoodCMLazzariniRA. Disrupted proteolipid protein trafficking results in oligodendrocyte apoptosis in an animal model of Pelizaeus-Merzbacher disease. J Cell Biol. 1998;140(4):925–934.
15.
NanceMABoyadjievSPrattVM, et al.Adult-onset neurodegenerative disorder due to proteolipid protein gene mutation in the mother of a man with Pelizaeus-Merzbacher disease. Neurology. 1996;47(5):1333–1335.
16.
RaskindWHWilliamsCAHudsonLDBirdTD. Complete deletion of the proteolipid protein gene (PLP) in a family with X-linked Pelizaeus-Merzbacher disease. Am J Hum Genet. 1991;49(6):1355–1360.
17.
SistermansEAde WijsIJde CooRF, et al.A (G-to-A) mutation in the initiation codon of the proteolipid protein gene causing a relatively mild form of Pelizaeus-Merzbacher disease in a Dutch family. Hum Genet. 1996;97(3):337–339.
18.
InoueKOsakaHThurstonVC, et al.Genomic rearrangements resulting in PLP1 deletion occur by nonhomologous end joining and cause different dysmyelinating phenotypes in males and females. Am J Hum Genet. 2002;71(4):838–853.
19.
HodesMEDeMyerWEPrattVM, et al.Girl with signs of Pelizaeus-Merzbacher disease heterozygous for a mutation in exon 2 of the proteolipid protein gene. Am J Med Genet. 1995;55(4):397–401.
20.
InoueKTanakaHScagliaF, et al.Compensating for central nervous system dysmyelination: females with a proteolipid protein gene duplication and sustained clinical improvement. Ann Neurol. 2001;50(6):747–754.
21.
RoganPKSvojanovskySLeederJS. Information theory-based analysis of CYP2C19, CYP2D6 and CYP3A5 splicing mutations. Pharmacogenetics. 2003;13(4):207–218.
22.
NallaVKRoganPK. Automated splicing mutation analysis by information theory. Hum Mutat. 2005;25(4):334–342.
23.
ChomczynskiPSacchiN. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162(1):156–159.
24.
CaillouxFGauthier-BarichardFMimaultC, et al.Genotype-phenotype correlation in inherited brain myelination defects due to proteolipid protein gene mutations. Clinical European Network on Brain Dysmyelinating Disease. Eur J Hum Genet. 2000; 8(11):837–845.
25.
SteccaBSouthwoodCMGragerovA, et al.The evolution of lipophilin genes from invertebrates to tetrapods: DM-20 cannot replace proteolipid protein in CNS myelin. J Neurosci. 2000;20(11):4002–4010.
26.
HobsonGMHuangZSperleK, et al.Splice-site contribution in alternative splicing of PLP1 and DM20: molecular studies in oligodendrocytes. Hum Mutat. 2006;27(1):69–77.
27.
SouthwoodCMGarbernJJiangWGowA. The unfolded protein response modulates disease severity in Pelizaeus-Merzbacher disease. Neuron. 2002;36(4):585–596.
28.
HubnerCAOrthUSenningA, et al.Seventeen novel PLP1 mutations in patients with Pelizaeus-Merzbacher disease. Hum Mutat. 2005;25(3):321–322.
29.
VelaJMGonzalezBCastellanoB. Understanding glial abnormalities associated with myelin deficiency in the jimpy mutant mouse. Brain Res Brain Res Rev. 1998;26(1):29–42.
30.
AoyagiYKobayashiHTanakaK, et al.A de novo splice donor site mutation causes in-frame deletion of 14 amino acids in the proteolipid protein in Pelizaeus-Merzbacher disease. Ann Neurol. 1999;46(1):112–115.
31.
GriffithsIRMontaguePDickinsonP. The proteolipid protein gene. Neuropathol Appl Neurobiol. 1995;21(2):85–96.
32.
PuckettCHudsonLOnoK, et al.Myelin-specific proteolipid protein is expressed in myelinating Schwann cells but is not incorporated into myelin sheaths. J Neurosci Res. 1987;18(4):511–518.
33.
GowAGragerovAGardA, et al.Conservation of topology, but not conformation, of the proteolipid proteins of the myelin sheath. J Neurosci. 1997;17(1):181–189.
34.
YamaguchiYIkenakaKNiinobeM, et al.Myelin proteolipid protein (PLP), but not DM-20, is an inositol hexakisphosphate-binding protein. J Biol Chem. 1996;271(44):27838–27846.
35.
Vaurs-BarriereCWongKWeibelTD, et al.Insertion of mutant proteolipid protein results in missorting of myelin proteins. Ann Neurol. 2003;54(6):769–780.
36.
GarbernJYCambiFLewisR, et al.Peripheral neuropathy caused by proteolipid protein gene mutations. Ann N Y Acad Sci. 1999;883:351–365.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
